PEPG PepGen Corp: Market Value

Public company logo of PepGen Corp (PEPG)

PepGen Inc. (PEPG) specializes in developing innovative DNA correction methods to combat muscle pathologies, fostering scientific partnerships with specialized clinics. This daily price chart is accompanied by the 0.37 indicator. EDO technology provides the company with exceptional pricing power due to low demand elasticity; however, the absence of sales and potential FDA approval hurdles render the return on R&D investment uncertain.

PepGen Inc - PEPG Market Capitalization (period 04/28/2023 - 11/12/2026)
Product sample of PepGen Inc

Market capitalization is calculated as the product of the current share price and the total number of outstanding securities. This metric determines the aggregate market value of the business, allowing for an assessment of the enterprise's scale and the risk of overpayment. For PepGen Inc. (PEPG), this value is supported by the implementation of sustainable oligonucleotide synthesis standards and strict ethics. By analyzing the capitalization dynamics of a public company, an investor determines the issuer's resilience to market shocks.

Key competitors

Market Capitalization BIIB (Biogen)|Neurocrine (NBIX) - Market Value|RGC - Market Value|Market Valuation AXSM|ACAD: Market Capitalization|Market Capitalization xenon-pharma.com XENE|Market Value Viking Therapeutics, Inc.|Market Capitalization SUPN (Supernus Pharmaceuticals, Inc.)|Market Capitalization CPRX|DNLI - Market Value|Harmony Biosciences - Market Valuation|Market Capitalization biohavenpharma.com BHVN|AMLX - Market Value|Market Value TRVI (Trevi Therapeutics Inc)|Praxis Medicines (PRAX) - Market Value|Market Value Anavex Life Sciences Corp (AVXL)|Market Value CeriBell, Inc.|Prothena Corp - Market Valuation|Market Capitalization ALEC|ANNX - Market Value|Market Value Omeros OMER|NGNE (Neurogene Therapeutics) - Market Valuation|AC Immune - Market Capitalization|Market Capitalization voyagertherapeutics.com (VYGR)|NMRA: Market Capitalization|Market Value Scilex Holding (SCLX)|Market Value Tevogen Bio Holdings, Inc.|Market Capitalization ACOG (Alpha Cognition Corp)|Market Valuation CGTX (Cognition Therapeutics, Inc.)|IKT (inhibikase.com) - Market Value|Market Capitalization SAVA (Cassava Sciences)|Market Capitalization Assertio Holdings (ASRT)|COYA - Market Value|VTGN (Vistagen Therapeutics) - Market Capitalization|OVID: Market Capitalization|Market Valuation acumenpharm.com|Market Valuation CRVO|Alterity Therapeutics Ltd (ATHE) - Market Capitalization|Market Value Clene Inc. (CLNN)|JUNS: Market Valuation|Market Capitalization RLMD (Relmada Therapeutics)|annovisbio.com (ANVS) - Market Value|GRCE - Market Value|Market Valuation AIFF|KLTO: Market Capitalization|Market Capitalization NeuroSense Therapeutics Ltd. NRSN|Market Value Reviva Pharmaceuticals|Market Capitalization MTVA (MetaVia, Inc.)|Market Capitalization NRXS|HSDT - Market Value|Passage Bio - Market Valuation|Market Capitalization Neuphoria Therapeutics, Inc. NEUP|NERV - Market Value|Market Value ATHA (athira.com)|Addex Therapeutics Ltd (ADXN) - Market Value|Market Value Alzamend Neuro (ALZN)|Market Value Cyclerion Therapeutics Inc.|Protagenic - Market Valuation|Market Capitalization KTTA|CRGT - Market Value|Market Value Avenue Therapeutics, Inc. ATXI|BCLI (Brainstorm Cell Therapeutics Inc.) - Market Valuation|Cara Therapeutics, Inc - Market Capitalization|Market Capitalization Chromocell (CHRO)|ELYM: Market Capitalization|Market Value Intra-Cellular Therapies, Inc. (ITCI)|Market Value Longboard Pharmaceuticals, Inc.|Market Capitalization MRNS (Marinus Pharmaceuticals Inc)|Market Valuation NKGN (NKGen)|NRBO (NeuroBo Pharma) - Market Value|Market Capitalization SAGE (Sage Therapeutics, Inc.)|Market Capitalization synaptogen.com (SNPX)|TRVN - Market Value|VIGL (Vigil Neuroscience) - Market Capitalization|WENA: Market Capitalization|Market Valuation Cerevel Corp